Brooke Harmon

ORCID: 0000-0003-0621-5320
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • vaccines and immunoinformatics approaches
  • Viral Infections and Vectors
  • Respiratory viral infections research
  • Viral Infections and Outbreaks Research
  • CRISPR and Genetic Engineering
  • Computational Drug Discovery Methods
  • HIV Research and Treatment
  • Bacteriophages and microbial interactions
  • Mosquito-borne diseases and control
  • HIV/AIDS drug development and treatment
  • Protein Structure and Dynamics
  • Influenza Virus Research Studies
  • Immunotherapy and Immune Responses
  • SARS-CoV-2 detection and testing
  • Complement system in diseases
  • Advanced biosensing and bioanalysis techniques
  • COVID-19 Impact on Reproduction
  • Biomedical and Engineering Education
  • Hepatitis B Virus Studies
  • Ethics and Legal Issues in Pediatric Healthcare
  • interferon and immune responses
  • Inhalation and Respiratory Drug Delivery
  • RNA Interference and Gene Delivery

Sandia National Laboratories California
2013-2025

Duke University
2023

Sandia National Laboratories
2019-2021

Lawrence Livermore National Security
2019

Washington University in St. Louis
2007-2010

Abstract Engineered monoclonal antibodies have proven to be highly effective therapeutics in recent viral outbreaks. However, despite technical advancements, an ability rapidly adapt or increase antibody affinity and by extension, therapeutic efficacy, has yet fully realized. We endeavored stand‐up such a pipeline using molecular modeling combined with experimental library screening the of F5, potent neutralizing activity against Venezuelan Equine Encephalitis Virus (VEEV), recombinant VEEV...

10.1002/pro.70043 article EN cc-by Protein Science 2025-01-22

Entry of human immunodeficiency virus type 1 (HIV-1) commences with binding the envelope glycoprotein (Env) to receptor CD4, and one two coreceptors, CXCR4 or CCR5. Env-mediated signaling through coreceptor results in Galphaq-mediated Rac activation actin cytoskeleton rearrangements necessary for fusion. Guanine nucleotide exchange factors (GEFs) activate regulate its downstream protein effectors. In this study we show that Env-induced is mediated by GEF Tiam-1, which associates adaptor...

10.1371/journal.ppat.1000956 article EN cc-by PLoS Pathogens 2010-06-17

ABSTRACT Rift Valley fever virus (RVFV) is a zoonotic pathogen capable of causing serious morbidity and mortality in both humans livestock. The lack efficient countermeasure strategies, the potential for dispersion into new regions, pathogenesis livestock make RVFV public health concern. receptors, cellular factors, entry pathways used by other members family Bunyaviridae remain largely uncharacterized. Here we provide evidence that strain MP-12 uses dynamin-dependent caveola-mediated...

10.1128/jvi.02242-12 article EN Journal of Virology 2012-09-20

The COVID-19 pandemic underscored the promise of monoclonal antibody-based prophylactic and therapeutic drugs

10.1038/s41586-024-07385-1 article EN cc-by Nature 2024-05-08

Binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) with the primary receptor CD4 and one two coreceptors, CXCR4 or CCR5, activates a signaling cascade resulting in Rac-1 GTPase activation stimulation actin cytoskeletal reorganizations critical for HIV-1-mediated membrane fusion. The mechanism by which HIV-1 Env induces subsequent cytoskeleton rearrangement is unknown. In this study, we show that Env-mediated dependent on Galpha(q) its downstream targets....

10.1128/jvi.00424-08 article EN Journal of Virology 2008-07-17

Paramyxoviruses initiate entry through the concerted action of tetrameric attachment glycoprotein (HN, H, or G) and trimeric fusion (F). The ectodomains HN/H/G contain a stalk region important for oligomeric stability F triggering resulting in membrane fusion. Paramyxovirus HN, G form dimer-of-dimers consisting disulfide-linked dimers their domain cysteines. protein highly pathogenic Nipah virus (NiV) contains distinct but uncharacterized cluster three cysteine residues (C146, C158, C162)....

10.1128/jvi.00076-12 article EN Journal of Virology 2012-04-12

The development of specific, safe, and potent monoclonal antibodies (Abs) has led to novel therapeutic options for infectious disease. In addition preventing viral infection through neutralization, Abs can clear infected cells induce immunomodulatory functions engagement their crystallizable fragment (Fc) with complement proteins Fc receptors on immune cells. Little is known about the role effector neutralizing in context encephalitic alphavirus infection. To determine function efficacy...

10.1080/19420862.2023.2297451 article EN cc-by-nc mAbs 2024-01-03

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to persist, demonstrating the risks posed by emerging infectious diseases national security, public health, and economy. Development of new vaccines antibodies for viral threats requires substantial resources time, traditional development platforms are often too slow combat continuously evolving immunological escape variants, reducing their efficacy over time. Previously, we designed a next-generation synthetic humanized...

10.1371/journal.ppat.1012903 article EN cc-by PLoS Pathogens 2025-01-23

ABSTRACT Rift Valley fever virus (RVFV) is an arbovirus within the Bunyaviridae family capable of causing serious morbidity and mortality in humans livestock. To identify host factors involved bunyavirus replication, we employed genome-wide RNA interference (RNAi) screening identified 381 genes whose knockdown reduced infection. The Wnt pathway was most represented when gene hits were functionally clustered. With further investigation, found that RVFV infection activated signaling, enhanced...

10.1128/jvi.00543-16 article EN cc-by Journal of Virology 2016-05-26

A rapid response is necessary to contain emergent biological outbreaks before they can become pandemics. The novel coronavirus (SARS-CoV-2) that causes COVID-19 was first reported in December of 2019 Wuhan, China and reached most corners the globe less than two months. In just over a year since initial infections, infected almost 100 million people worldwide. Although similar SARS-CoV MERS-CoV, SARS-CoV-2 has resisted treatments are effective against other coronaviruses. Crystal structures...

10.3389/fmolb.2021.678701 article EN cc-by Frontiers in Molecular Biosciences 2021-07-09

While the IMRAD (Introduction, Methods, Results, and Discussion) format is common in scientific writing, it may not currently be as ubiquitous often thought. We undertook a systematic, corpus-based study of primary section headings research articles across range STEM disciplines to investigate adherence structure relation type (computational, empirical, or theoretical) field. identified four categories structure: IMRAD, IMRAD+ (IMRAD with additional sections and/or different order), Nested...

10.1177/00472816231171851 article EN Journal of Technical Writing and Communication 2023-05-23

Combined activity- and immunoassays for CRISPR/Cas9 on a portable microfluidic device with integrated sample preparation from clinical matrices.

10.1039/c8ay02726a article EN Analytical Methods 2019-01-01

The respiratory virus responsible for coronavirus disease 2019 (COVID-19), severe acute syndrome 2 (SARS-CoV-2), has affected nearly every aspect of life worldwide, claiming the lives over 3.9 million people globally, at time this publication. Neutralizing humanized nanobody (VHH)-based antibodies (VHH-huFc) represent a promising therapeutic intervention strategy to address current SARS-CoV-2 pandemic and provide powerful toolkit future outbreaks. Using synthetic, high-diversity VHH...

10.1080/19420862.2021.1958663 article EN cc-by-nc mAbs 2021-01-01

The high-affinity receptor for IgE expressed on the surface of mast cells and basophils interacts with antigens, via bound antibody, triggers secretion inflammatory mediators that contribute to allergic reactions. To understand how past inputs (memory) influence future responses in cells, a microfluidic device was used precisely control exposure alternating stimulatory non-stimulatory inputs. We determined response subsequent stimulation depends interval signaling quiescence. For shorter...

10.1038/s41598-017-15568-2 article EN cc-by Scientific Reports 2017-11-08

The RNA-guided DNA nuclease Cas9 is now widely used for the targeted modification of genomes human cells and various organisms. Despite extensive use Clustered Regularly Interspaced Palindromic Repeats (CRISPR) systems genome engineering rapid discovery new CRISPR-associated nucleases, there are no high-throughput assays measuring enzymatic activity. current laboratory future therapeutic uses CRISPR technology have a significant risk accidental exposure or clinical off-target effects,...

10.1021/acs.analchem.8b01155 article EN Analytical Chemistry 2018-05-14

RNA interference (RNAi) is a powerful tool for functional genomics with the capacity to comprehensively analyze host–pathogen interactions. High-throughput RNAi screening used systematically perturb cellular pathways and discover therapeutic targets, but method can be tedious requires extensive capital equipment expensive reagents. To aid in development of an inexpensive miniaturized platform, we have developed two part microfluidic system patterning gene targets on-chip examine involved...

10.1039/c2lc41165b article EN Lab on a Chip 2013-01-01

Structure-based Deep Fusion models were recently shown to outperform several physics- and machine learning-based protein-ligand binding affinity prediction methods. As part of a multi-institutional COVID-19 pandemic response, over 500 million small molecules computationally screened against four protein structures from the novel coronavirus (SARS-CoV-2), which causes COVID-19. Three enhancements made in order evaluate more than 5 billion docked poses on SARS-CoV-2 targets. First, concept was...

10.1145/3458817.3476193 article EN cc-by 2021-10-21

ABSTRACT Engineered monoclonal antibodies (mAbs) have proven to be highly effective therapeutics in recent viral outbreaks due their specificity and ability provide immediate protection, regardless of immune status. However, despite technical advancements the field, an rapidly adapt or increase antibody affinity by extension, therapeutic efficacy, has yet fully realized. We endeavored stand-up such a pipeline using molecular modeling combined with experimental library screening given...

10.1101/2024.07.08.602599 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-07-09

Structure-based Deep Fusion models were recently shown to outperform several physics- and machine learning-based protein-ligand binding affinity prediction methods. As part of a multi-institutional COVID-19 pandemic response, over 500 million small molecules computationally screened against four protein structures from the novel coronavirus (SARS-CoV-2), which causes COVID-19. Three enhancements made in order evaluate more than 5 billion docked poses on SARS-CoV-2 targets. First, concept was...

10.48550/arxiv.2104.04547 preprint EN cc-by-nc-nd arXiv (Cornell University) 2021-01-01
Coming Soon ...